Navigation Links
Repligen Announces ISO 9001:2000 Certification
Date:2/12/2009

WALTHAM, Mass., Feb. 12 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN), a global leader in the manufacture of recombinant Protein A products, announced today that the Company has received ISO 9001:2000 (ISO) certification, the international standard for best practices for manufacturing and quality systems. ISO certification was granted for the quality management system supporting the manufacture of products and related services underlying its Protein A business. Repligen has supplied Protein A products to the biopharmaceutical industry for more than 20 years and pursued ISO certification to demonstrate that its operations meet the high quality standard which has global acceptance within the industry.

"We are very proud to have received ISO certification for our Protein A business, a milestone that reinforces our longstanding commitment to quality and customer satisfaction," said Walter C. Herlihy, President and Chief Executive Officer of Repligen.

Repligen is the world's leading supplier of recombinant Protein A, a consumable used in the manufacture of therapeutic monoclonal antibodies. There are approximately 20 monoclonal antibodies that have received regulatory approval with more than 200 products in various stages of clinical development. The worldwide revenues from this class of drug were approximately $35 billion in 2008. Monoclonal antibodies are the largest and one of the fastest growing classes of drug in the biopharmaceutical industry.

ISO 9001:2000 is a quality management system standard that represents an international consensus on the best quality management practice. Created and published by the International Organization for Standardization, a network of the national standards institutes representing 160 countries, ISO standards define globally relevant management and process re
'/>"/>

SOURCE Repligen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Repligen Reports Second Quarter Fiscal Year 2009 Financial Results
2. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
3. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
4. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
5. Repligen Announces Share Repurchase Program
6. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
7. Repligen Elects Earl Henry, M.D. to the Board of Directors
8. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
9. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
10. Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
11. Palatin Technologies Announces Receipt of $4.1 Million from AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Thousand Oaks, CA (PRWEB) , ... August 31, ... ... has recently been updated to include a wealth of information for specific translation ... Translations has great expertise and an incredible track record of successful work. , ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... In ... by CDA Press, the expert guest author addressed the topic of treating back pain ... explained that, while steroids were shown to slightly improve physical function in patients suffering ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s ... that is unique to the Lake Orion area. This program is one of ... , WEmovestrong’s weight management program will incorporate group fitness and nutritional consultations to ...
(Date:8/31/2015)... ... , ... Patients who thought about getting a hair transplant but were not ... the procedure beyond the information found on the Internet can attend the open house ... will be on hand to answer patients hair transplant questions at his next ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... In ... article from the Plastic and Reconstructive Surgery Global Open Journal that discusses the future ... The article discussed how, in the future, customized implants, prosthetics, and other 3-D printed ...
Breaking Medicine News(10 mins):Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3
... employees with health and wellness resources , ... Amex: FIT ) today announced a partnership ... a comprehensive health management program for more than 17,000 ... , Neb. Gov. Dave Heineman outlined the ...
... dominate the headlines, a private business continues to find ... of alcohol misuse and abuse. Innocorp President Michael Aguilar ... Drunk Driving, Mr. Glynn Birch, has been named as ... , , "No one is above the ...
... of non-smoking New Yorkers have elevated levels of cotinine ... exposed to toxic second-hand smoke in concentrations high enough ... of nicotine breakdown, is not harmful itself but signals ... published online this week in the journal Nicotine ...
... juice and chalky fiber supplements, just sit down and relax. ... online in The FASEB Journal ( http://www.fasebj.org ), ... make it a lot easier to go to the bathroom, ... a group of nerve ending receptors which, when stimulated, causes ...
... American Heart Association has partnered with Wiley-Blackwell to ... American Heart Association Clinical Series, designed to help ... patient care. , Each hardcover volume focuses ... on their areas of individual expertise under the ...
... manufacturers unique ,superfruits, opportunityPURCHASE, N.Y., April 8 /PRNewswire/ ... attained self-affirmed GRAS status. An independent panel ... evaluation of research and toxicology data. Oligonol(R) ... in food products and supplements. Oligonol(R), which features ...
Cached Medicine News:Health News:HealthFitness Announces New Employee Health Partnership With State of Nebraska 2Health News:Innocorp, ltd. Hires Former MADD National President 2Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 2Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 3Health News:Blood tests reveal tobacco smoke residues in non-smoking New Yorkers 4Health News:Prune juice not necessary: New research should make bowel movements easier 2Health News:Wiley-Blackwell and the American Heart Association present new book series 2Health News:Oligonol(R) Lychee Fruit Polyphenols Attains Self-Affirmed GRAS (Generally Recognized As Safe) Status 2
(Date:8/31/2015)... Aug. 31, 2015  Asterias Biotherapeutics, Inc. (NYSE ... emerging field of regenerative medicine, today announced that ... Chicago -based Rush University Medical Center ... of escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) ... complete cervical spinal cord injury (SCI). This represents ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
(Date:8/28/2015)... JACKSONVILLE, Fla. , Aug. 28, 2015  With ... reaching deadlier heights, Jacksonville ... Philip Hemphill is helping to explain why ... Fentanyl is approximately 40 to 50 times more potent ... by recreational users as heroin, the risk of death ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... use with the Moto Alpha unit, these new pads ... in which several successive runs may be sealed with ... to prevent a microplate from sticking to the block ... level of sealing performance, which means you can use ...
... Designed for use with the Moto Alpha unit, these ... cycle sequencing, in which several successive runs may be ... Alpha unit is engineered to prevent a microplate from ... pads provide an improved level of sealing performance, which ...
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
Omniseal TD mat. Reusable rubber mat for sealing PCR plates. 5 pk....
Medicine Products: